LY3039478 has been used in trials studying the treatment and basic science of LYMPHOMA, Neoplasms, Solid Tumor, COLON CANCER, and BREAST CANCER, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.